Seawolf Therapeutics has raised $100 million in a seed funding round led by Versant Ventures. The funding will be used to advance their proprietary DNA delivery platform for better patient outcomes.
Amount Raised
$100 Million
Round Type
Seed
Investors
Description
Seawolf Therapeutics has emerged from stealth with an announcement of raising $100 million. The financing aims to transform patient outcomes utilizing its innovative DNA-based therapeutics. The seed round was led by Versant Ventures, with participation from other notable investors. The company plans to use the funds to further develop its proprietary platform.
Quick answer
Seawolf Therapeutics raised $100 Million in a Seed round, dated November 16, 2026. Investors: MPM BioImpact, Novartis Venture Fund, Eli Lilly And Company, CRISPR Therapeutics AG, Sixty Degree Capital, Alexandria Venture Investments and Versant Ventures. Seawolf Therapeutics is based in San Diego, California, United States.
- How much did Seawolf Therapeutics raise?
- Seawolf Therapeutics raised $100 Million in a Seed round on November 16, 2026.
- Who invested in Seawolf Therapeutics?
- MPM BioImpact, Novartis Venture Fund, Eli Lilly And Company, CRISPR Therapeutics AG, Sixty Degree Capital, Alexandria Venture Investments and Versant Ventures are named as investors in this round.
- What does Seawolf Therapeutics do?
- Seawolf Therapeutics is focused on developing DNA-based therapeutics to transform patient outcomes.
- Where is Seawolf Therapeutics based and how big is it?
- Seawolf Therapeutics is based in San Diego, California, United States.
- Who are the decision-makers at Seawolf Therapeutics?
- Fundz holds 1 contact at Seawolf Therapeutics, including the Associate Director, Business Development. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Seawolf Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- 201 Therapeutics raised $178K (Seed) on November 16, 2026.
- Yicura BioMed raised an undisclosed amount (Series B) on November 13, 2026.
- Lifeplex Science raised $5.3M (Series A) on November 13, 2026.
- Orakl Oncology raised $34M (Series A) on November 12, 2026.
- VectorY raised $83M on November 11, 2026.
- Neurosterix raised $105M (Series B) on November 11, 2026.
Who to call at Seawolf Therapeutics, and when
A new round usually means Seawolf Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Seawolf Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Seawolf Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Seawolf Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Seawolf Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Seawolf Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.